Park Avenue Securities’s Labcorp LH Stock Holding History
Bought
Maintained
Sold
Other funds holding LH
RRAM
JIC
BCWM
AAM
DIA
SFA
WCM
HPCM
MCM
ET
Park Avenue Securities's LH Position: Q2 2026 in Review
Park Avenue Securities increased its Labcorp (LH) stake by 5.6% in Q2 2026, buying an estimated $72.6K and bringing the position to 5,179 shares worth $1.45M. The position accounts for 0.01% of the portfolio, ranked #795.
Park Avenue Securities first reported a position in LH in Q3 2018 and has held it in 25 quarters since. The position peaked at $2.08M in Q4 2023. 265 funds tracked by Wall St. Rank hold LH as of Q2 2026.
- Park Avenue Securities held 5,179 shares of Labcorp worth $1.45M as of Q2 2026.
- Park Avenue Securities bought 276 Labcorp shares in Q2 2026, an estimated $72.6K.
- Labcorp made up 0.01% of Park Avenue Securities's portfolio in Q2 2026, its #795 holding.
- Park Avenue Securities first reported a position in Labcorp in Q3 2018 and has held it in 25 quarters since.
- Park Avenue Securities's Labcorp position peaked at $2.08M in Q4 2023.
- 265 funds tracked by Wall St. Rank held Labcorp as of Q2 2026.
Based on Park Avenue Securities's 13F filing for Q2 2026, filed 20 Jul 2026.